Adamas Announces Publication of the Two-Year Phase 3 Open-Label EASE LID 2 Trial of GOCOVRI® for Dyskinesia in Patients with Parkinson’s Disease. Sometimes the dyskinesia…
Dedicated Providers & Partners - this is for you, our more than 100 movement disorder specialists, nurse practitioners, physician assistants, and other healthcare providers! It…
One of the important factors for getting a smooth response from your Parkinson disease (PD) medications is recognizing the signs and symptoms of PD that…